Esoxia-D Capsule SR is a combination medication containing Domperidone 30mg and Esomeprazole 40mg, designed to provide effective relief from gastrointestinal disorders. Domperidone is a prokinetic agent that enhances gastrointestinal motility by blocking dopamine receptors, thereby facilitating faster gastric emptying and reducing symptoms such as nausea, vomiting, and bloating. Esomeprazole, a proton pump inhibitor, works by suppressing gastric acid secretion, promoting healing of acid-related damage in the stomach and esophagus, and providing relief from conditions like gastroesophageal reflux disease (GERD), peptic ulcers, and Zollinger-Ellison syndrome. The sustained-release formulation of Esoxia-D Capsule SR ensures prolonged therapeutic action, improving patient compliance by reducing dosing frequency. This combination is particularly beneficial for patients experiencing delayed gastric emptying accompanied by excessive acid production, offering symptomatic relief and promoting mucosal healing. It is generally well-tolerated, but patients should use it under medical supervision, especially those with liver impairment, cardiac conditions, or on medications that may interact with Domperidone or Esomeprazole. Esoxia-D Capsule SR should be taken as prescribed, typically before meals, to maximize its efficacy in managing upper gastrointestinal symptoms and improving overall digestive health.